Skip to Content

PAD 134 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 15 mg)

Pill with imprint PAD 134 is White, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 15 mg. It is supplied by Paddock Laboratories, Inc..

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAD 134

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg PAD 134

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
PAD 134
Strength
12.5 mg / 15 mg
Color
White
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Paddock Laboratories, Inc.
National Drug Code (NDC)
00574-0134
Inactive Ingredients
lactose, magnesium oxide, crospovidone, magnesium stearate, povidone, silicon dioxide, hypromelloses, titanium dioxide, polyethylene glycol 400, polysorbate 80

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.